Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP405275.RAJvrtdSYIb2SNFTu8ePl24C3n_ejWNjp57y-hy0QFrdM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP405275.RAJvrtdSYIb2SNFTu8ePl24C3n_ejWNjp57y-hy0QFrdM130_assertion type Assertion NP405275.RAJvrtdSYIb2SNFTu8ePl24C3n_ejWNjp57y-hy0QFrdM130_head.
- NP405275.RAJvrtdSYIb2SNFTu8ePl24C3n_ejWNjp57y-hy0QFrdM130_assertion description "[The duration of survival of patients whose tumors exhibited well-differentiated gastrin-positive tumor (GPT) cells (n = 12) was significantly poorer than that of patients whose tumors were GPT-negative (5-year survival, 30% vs 54%; P = 0.037).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405275.RAJvrtdSYIb2SNFTu8ePl24C3n_ejWNjp57y-hy0QFrdM130_provenance.
- NP405275.RAJvrtdSYIb2SNFTu8ePl24C3n_ejWNjp57y-hy0QFrdM130_assertion evidence source_evidence_literature NP405275.RAJvrtdSYIb2SNFTu8ePl24C3n_ejWNjp57y-hy0QFrdM130_provenance.
- NP405275.RAJvrtdSYIb2SNFTu8ePl24C3n_ejWNjp57y-hy0QFrdM130_assertion SIO_000772 17922093 NP405275.RAJvrtdSYIb2SNFTu8ePl24C3n_ejWNjp57y-hy0QFrdM130_provenance.
- NP405275.RAJvrtdSYIb2SNFTu8ePl24C3n_ejWNjp57y-hy0QFrdM130_assertion wasDerivedFrom befree-20140225 NP405275.RAJvrtdSYIb2SNFTu8ePl24C3n_ejWNjp57y-hy0QFrdM130_provenance.
- NP405275.RAJvrtdSYIb2SNFTu8ePl24C3n_ejWNjp57y-hy0QFrdM130_assertion wasGeneratedBy ECO_0000203 NP405275.RAJvrtdSYIb2SNFTu8ePl24C3n_ejWNjp57y-hy0QFrdM130_provenance.